Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: A systematic review and meta-analysis
Số trang: 14
Loại file: pdf
Dung lượng: 3.97 MB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Patients with rheumatologic preexisting autoimmune disease (PAD) have not been enrolled in clinical trials of immune checkpoint inhibitors (ICIs). Therefore, the risks and benefits of ICI therapy in such patients are unclear. Herein, we investigated the safety and efficacy of ICIs in rheumatologic PAD patients through a meta-analysis.
Nội dung trích xuất từ tài liệu:
Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: A systematic review and meta-analysis
Nội dung trích xuất từ tài liệu:
Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: A systematic review and meta-analysis
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Rheumatologic preexisting autoimmune diseases Immune checkpoint inhibitors Immune-related adverse events Meta-analysisGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 167 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 109 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 35 0 0
-
12 trang 33 0 0